http://www.searchforvideo.com SearchForVideo.com Betaseron videos http://www.metacafe.com/watch/1450949/barriers_prevent_people_with_ms_from_committing_to_treatment/ Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of people with MS, results of which were released today at the Consortium of Multiple Sclerosis Centers annual meeting in Denver. However, the survey also found that people with the disease can face significant barriers that make it difficult for them to start or stay fully committed to an effective treatment regimen. For more information on this story and others, visit www.newsinfusion.com Ranked 3.33 / 5 | 92 views | 0 comments Click here to watch the video (01:00) Submitted By: NewsInfusion Tags: Betaseron   Betaplus   Bayer   Healthcare   Pharmaceuticals   Inc.   Copaxone   Rebif   Multiple   Sclerosis   Ms   Survey   Categories: News & Events http://www.metacafe.com/watch/750599/landmark_study_in_the_lancet_patients_treated_with_betaseron_af/ Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS Progression Patients treated with Betaseron (interferon beta-1b) shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed disability progression compared to patients in whom treatment was delayed. The results which were fast-tracked and published in The Lancet this week provide the first controlled evidence that delaying Betaseron treatment has an effect on later accumulation of disability, as observed over the three-year study period. No other MS therapy has demonstrated this effect in this early patient population. The BENEFIT study (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), sponsored by Bayer HealthCare, compared Betaseron treatment initiated after a first clinical event with delayed treatment. The study was conducted at 98 sites in 20 countries and included a total of 468 patients. Ranked 2.38 / 5 | 236 views | 0 comments Click here to watch the video (01:34) Submitted By: MultiVu Tags: Lancet   Ms   Betaseron   Benefit   Study   Bayer   HealthCare   Www.betaseron.com   Multivu   29192   Categories: News & Events http://youtube.com/?v=oHhmCAnIXqg Author: cliff501 Keywords: tysabri uti multiple sclerosis infusion infection ms copaxone betaseron Added: July 4, 2008 http://youtube.com/?v=amHEacfzYUQ Author: UMMCVideos Keywords: royal walter royal neurology multiple sclerosis ms symptoms diagnosis treatment research avonex betaseron copaxone rebif therapy mht ummc Added: September 20, 2008 http://youtube.com/?v=0toaTlu-Loc Author: products4health Keywords: multiple sclerosis cure new drug betaseron MS MS150 MSBikeRide MSwalk Val Moffat Added: March 21, 2009 http://youtube.com/?v=3Md_im608yg Author: notmil0 Keywords: multiple sclerosis MS injection Added: September 26, 2009 http://xml.truveo.com/rd?i=1572383416&a=rss&p=7&h=4b0142ce4a23074:d9456532d09fe979a472ee939f2cb2eb Berlex, Inc. has issued a reminder to practitioners about the possible hepatotoxicity of Betaseron (interferon beta-1b), which is used to treat relapsing forms of multiple sclerosis. The company's letter notes that there have been rare reports of serious hepatic injury leading to hepatic failure and transplant in patients on beta-interferon products. It reminds practitioners that the prescribing information for this drug recommends liver function tests at one, three and six months after starting Betaseron therapy, and periodically thereafter if the patient has no symptoms of liver toxicity. http://www.google.ca/url?q=http://www.youtube.com/watch%3Fv%3D3Md_im608yg&source=video&vgc=rss&usg=AFQjCNHhby9egogiIQANJ4_watT1Uulh_A This is a video I made of the first injection I gave myself of BetaSeron. This is my third injection and the first one I've done myself. I ... youtube.com http://www.google.ca/url?q=http://video.google.com/videoplay%3Fdocid%3D-1144692063527498288&source=video&vgc=rss&usg=AFQjCNGqKctUOg6x4umto6PThezqtKhsHg Landmark Study in The Lancet: Patients Treated With Betaseron® After First MS Attack Experienced Significant Delay in MS Progression Patients ... video.google.com http://www.google.ca/url?q=http://www.pandora.tv/channel/ch_main.asp%3Fch_userid%3Dmultivu%26id%3D31511617%26mode%3Dview%26redirect%3Dprg%26ref%3Dgoogle&source=video&vgc=rss&usg=AFQjCNEBpKDD_Sgh8rV1Ie-mzjoepGp6Ng Patients treated with Betaseron® (interferon beta-1b) shortly after their first clinical MS event or "attack" showed a 40 percent lower ... pandora.tv http://xml.truveo.com/rd?i=2086828287&a=rss&p=4&h=4b0142ce4a23074:d9456532d09fe979a472ee939f2cb2eb Video that was shot to promote BetaSeron featuring information regrading the drug and personal stories of those of us who live with MS. http://xml.truveo.com/rd?i=2772362217&a=rss&p=6&h=4b0142ce4a23074:d9456532d09fe979a472ee939f2cb2eb Landmark Study in The Lancet: Patients Treated With Betaseron® After First MS Attack Experienced Significant Delay in MS Progression Patients treated with Betaseron® (interferon beta-1b) shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of developing confirmed disability progression compared to patients in whom treatment was delayed. The results—which were fast-tracked and published in The Lancet this week—provide the first controlled evidence that delaying Betaseron treatment has an effect on later accumulation of disability, as observed over the three-year study period. No other MS therapy has demonstrated this effect in this early patient population. The BENEFIT study (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), sponsored by Bayer HealthCare, compared Betaseron treatment initiated after a first clinical event with delayed treatment. The study was conducted at 98 sites in 20 countries and included a total of 468 patients. http://revver.com/video/1220400/betaseron-to-offer-the-thinnest-needle-in-multiple-sclerosis/ Author: NewsInfusion Added: Fri, 03 Oct 2008 16:33:30 -0800 Duration: 48 For more information on this and other stories, visit www.newsinfusion.com Wayne, New Jersey, September 15, 2008 Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron (interferon beta-1b), its treatment for relapsing forms of multiple sclerosis (MS), will soon be available with a new 30-gauge needle, which will be the thinnest needle of any injectable disease-modifying therapy for people with MS. The new needle is as thin as the needle commonly used for insulin and pediatric injections. One of the barriers that many people with multiple sclerosis face in starting an MS treatment is injection anxiety," said Ludger Heeck, Vice President and General Manager, Specialty Medicine, Bayer HealthCare Pharmaceuticals Inc. "Betaseron is a safe and effective treatment for people with relapsing forms of MS, as well as those with the earliest signs of the disease. By introducing the thinnest needle of any injectable disease-modifying medication for MS, we are taking ... http://youtube.com/?v=vUrooG_g0as Author: Fripodaca Keywords: Multiple Sclerosis Injections Betaseron Avonex Rebif Capaxone Interferon Episode Fatigue Kung Fu Sexy Hot Virginia Slims Added: February 28, 2008 http://youtube.com/?v=m2JmLv2EQQ0 Author: lizzy890 Keywords: multiple Sclerosis Injections Betaseron Avonex Rebif Capaxone Interferon Episode Fatigue Kung Fu Sexy Hot Virginia Slims Added: April 3, 2008 http://youtube.com/?v=rFn9Ig0Od94 Author: lizzy890 Keywords: Multiple Sclerosis Injections Betaseron Avonex Rebif Capaxone Interferon Episode Fatigue Kung Fu Sexy Hot Virginia Slims Added: April 3, 2008 http://youtube.com/?v=iY5iwfCi9Ec Author: festygrrl Keywords: MS multiple sclerosis tysabri betaferon betaseron relapse methylprednisone muscle weakness medicine Added: June 10, 2008 http://www.veoh.com/browse/videos/category/technology_and_gaming/watch/v161375893F2Sb3Hh For more information on this and other stories, visit www.newsinfusion.com Wayne, New Jersey, September 15, 2008 – Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron (interferon beta-1b), its treatment for relapsing forms of multiple sclerosis (MS), will soon be available with a new 30-gauge needle, which will be the thinnest needle of any injectable disease-modifying therapy for people with MS. The new needle is as thin as the needle commonly used for insulin and pediatric injections. “One of the barriers that many people with multiple sclerosis face in starting an MS treatment is injection anxiety," said Ludger Heeck, Vice President and General Manager, Specialty Medicine, Bayer HealthCare Pharmaceuticals Inc. "Betaseron is a safe and effective treatment for people with relapsing forms of MS, as well as those with the earliest signs of the disease. By introducing the thinnest needle of any injectable disease-modifying medication for MS, we are taking another important step ... http://www.dailymotion.com/video/x5zf2x_barriers-prevent-people-with-ms-fro_news Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying...